Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHUKRA PHARMA vs CONCORD DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHUKRA PHARMA CONCORD DRUGS SHUKRA PHARMA/
CONCORD DRUGS
 
P/E (TTM) x 19.3 35.0 55.1% View Chart
P/BV x 14.1 1.1 1,288.5% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHUKRA PHARMA   CONCORD DRUGS
EQUITY SHARE DATA
    SHUKRA PHARMA
Mar-23
CONCORD DRUGS
Mar-23
SHUKRA PHARMA/
CONCORD DRUGS
5-Yr Chart
Click to enlarge
High Rs8942 213.0%   
Low Rs1120 57.0%   
Sales per share (Unadj.) Rs53.755.9 96.1%  
Earnings per share (Unadj.) Rs4.01.1 380.1%  
Cash flow per share (Unadj.) Rs5.72.8 203.4%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs23.133.4 69.1%  
Shares outstanding (eoy) m10.969.32 117.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.90.5 170.0%   
Avg P/E ratio x12.428.9 43.0%  
P/CF ratio (eoy) x8.810.9 80.3%  
Price / Book Value ratio x2.20.9 236.4%  
Dividend payout %12.40-   
Avg Mkt Cap Rs m547285 192.1%   
No. of employees `000NANA-   
Total wages/salary Rs m4438 114.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m588521 113.0%  
Other income Rs m120 13,300.0%   
Total revenues Rs m600521 115.2%   
Gross profit Rs m5446 117.3%  
Depreciation Rs m1816 113.0%   
Interest Rs m317 16.5%   
Profit before tax Rs m4412 355.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m03 13.3%   
Profit after tax Rs m4410 447.0%  
Gross profit margin %9.18.8 103.8%  
Effective tax rate %0.821.1 3.8%   
Net profit margin %7.51.9 395.8%  
BALANCE SHEET DATA
Current assets Rs m531435 122.1%   
Current liabilities Rs m425216 196.7%   
Net working cap to sales %18.041.9 42.8%  
Current ratio x1.22.0 62.1%  
Inventory Days Days07 0.0%  
Debtors Days Days1,8731,108 169.0%  
Net fixed assets Rs m219148 148.2%   
Share capital Rs m3993 42.0%   
"Free" reserves Rs m214218 98.0%   
Net worth Rs m253311 81.2%   
Long term debt Rs m3819 197.2%   
Total assets Rs m750582 128.7%  
Interest coverage x16.81.7 970.4%   
Debt to equity ratio x0.10.1 242.7%  
Sales to assets ratio x0.80.9 87.7%   
Return on assets %6.34.6 135.3%  
Return on equity %17.43.2 550.4%  
Return on capital %16.28.9 181.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m3217 190.6%  
From Investments Rs m-44-23 195.4%  
From Financial Activity Rs m496 791.8%  
Net Cashflow Rs m370 16,745.5%  

Share Holding

Indian Promoters % 51.0 55.4 92.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.1 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 44.6 110.0%  
Shareholders   10,963 4,032 271.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHUKRA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RELISH PHARMA vs CONCORD DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RELISH PHARMA vs CONCORD DRUGS Share Price Performance

Period RELISH PHARMA CONCORD DRUGS S&P BSE HEALTHCARE
1-Day -2.00% -4.87% 1.23%
1-Month 18.32% -12.82% -0.71%
1-Year 528.10% 29.21% 61.89%
3-Year CAGR 229.50% 5.24% 18.18%
5-Year CAGR 114.18% 11.07% 19.80%

* Compound Annual Growth Rate

Here are more details on the RELISH PHARMA share price and the CONCORD DRUGS share price.

Moving on to shareholding structures...

The promoters of RELISH PHARMA hold a 51.0% stake in the company. In case of CONCORD DRUGS the stake stands at 55.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RELISH PHARMA and the shareholding pattern of CONCORD DRUGS.

Finally, a word on dividends...

In the most recent financial year, RELISH PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 12.4%.

CONCORD DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of RELISH PHARMA, and the dividend history of CONCORD DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.